Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,227 | 190 | 99.2% |
| Education | $24.64 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,067 | 44 | $0 (2024) |
| Lilly USA, LLC | $409.13 | 27 | $0 (2024) |
| Novo Nordisk Inc | $312.40 | 23 | $0 (2023) |
| GlaxoSmithKline, LLC. | $261.60 | 17 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $245.30 | 15 | $0 (2022) |
| PFIZER INC. | $224.88 | 15 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $133.48 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $88.81 | 6 | $0 (2022) |
| Esperion Therapeutics, Inc. | $88.18 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $85.77 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $312.70 | 14 | AstraZeneca Pharmaceuticals LP ($143.83) |
| 2023 | $450.98 | 16 | AstraZeneca Pharmaceuticals LP ($223.95) |
| 2022 | $304.46 | 22 | Lilly USA, LLC ($53.16) |
| 2021 | $566.14 | 39 | Janssen Pharmaceuticals, Inc ($147.74) |
| 2020 | $567.78 | 37 | AstraZeneca Pharmaceuticals LP ($135.22) |
| 2019 | $257.55 | 12 | AstraZeneca Pharmaceuticals LP ($152.63) |
| 2018 | $400.17 | 23 | AstraZeneca Pharmaceuticals LP ($187.66) |
| 2017 | $391.76 | 29 | AstraZeneca Pharmaceuticals LP ($110.59) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Immunology | ||||||
| 08/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 05/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Respiratory | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: DIABETES | ||||||
| 03/11/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 03/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: DIABETES | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $69.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: VACCINES | ||||||
| 09/26/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes Care | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 06/06/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Diabetes | ||||||
| 06/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,104 | 1,655 | $186,843 | $110,590 |
| 2022 | 20 | 1,118 | 1,837 | $214,677 | $128,529 |
| 2021 | 22 | 1,316 | 1,961 | $236,913 | $149,771 |
| 2020 | 27 | 1,450 | 2,213 | $220,478 | $144,071 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 137 | $31,510 | $17,369 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 301 | $36,120 | $16,383 | 45.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 163 | $22,657 | $14,425 | 63.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $17,110 | $14,173 | 82.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 167 | $24,215 | $13,175 | 54.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 45 | 209 | $13,585 | $8,697 | 64.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 59 | 74 | $9,620 | $6,302 | 65.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 55 | $8,360 | $5,167 | 61.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 40 | 72 | $8,640 | $4,071 | 47.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 82 | $2,510 | $2,199 | 87.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $2,968 | $2,151 | 72.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 34 | $3,400 | $1,917 | 56.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 82 | 82 | $2,624 | $1,678 | 63.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 95 | 95 | $1,805 | $1,617 | 89.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $858.00 | $502.19 | 58.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 24 | 24 | $456.00 | $408.48 | 89.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 15 | 15 | $405.00 | $356.25 | 88.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 227 | $32,915 | $18,594 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 137 | 335 | $40,200 | $18,506 | 46.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 171 | $22,393 | $12,878 | 57.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $14,645 | $12,358 | 84.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 85 | $19,550 | $12,305 | 62.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 42 | 239 | $14,159 | $10,256 | 72.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 72 | 75 | $14,325 | $9,930 | 69.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 58 | 103 | $12,360 | $5,670 | 45.9% |
About Dr. Cyrus Joshi, M.D
Dr. Cyrus Joshi, M.D is a Internal Medicine healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083612287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cyrus Joshi, M.D has received a total of $3,252 in payments from pharmaceutical and medical device companies, with $312.70 received in 2024. These payments were reported across 192 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,227).
As a Medicare-enrolled provider, Joshi has provided services to 4,988 Medicare beneficiaries, totaling 7,666 services with total Medicare billing of $532,961. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Clarksville, IN
- Active Since 07/12/2005
- Last Updated 01/11/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083612287
Products in Payments
- FARXIGA (Drug) $1,010
- XARELTO (Drug) $232.18
- TRELEGY ELLIPTA (Drug) $170.69
- ELIQUIS (Drug) $170.47
- TRULICITY (Drug) $167.82
- Ozempic (Drug) $155.89
- Livalo (Drug) $133.48
- TRADJENTA (Drug) $93.18
- ENTRESTO (Drug) $88.81
- MOUNJARO (Drug) $80.20
- NEXLETOL (Drug) $75.46
- Victoza (Drug) $66.97
- JARDIANCE (Drug) $58.76
- EMGALITY (Drug) $57.14
- Prolia (Biological) $51.61
- CHANTIX (Drug) $45.93
- ANORO (Drug) $42.15
- COLOGUARD DNA CAPTURE REAGENTS (Device) $39.46
- Tresiba (Drug) $38.16
- AREXVY (Drug) $34.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clarksville
Stephen White, Md, MD
Internal Medicine — Payments: $15,089
Olaide Ajayi, M.d, M.D
Internal Medicine — Payments: $10,834
Dr. Devabrata Ganguly, M.d, M.D
Internal Medicine — Payments: $7,224
Dr. Marty Odom, Md, MD
Internal Medicine — Payments: $6,476
Steven Goldstein, Md, MD
Internal Medicine — Payments: $4,313
Giavonne Rondo-Hillman, Md, MD
Internal Medicine — Payments: $3,904